Handbook of Cannabis and Related Pathologies
Handbook of Cannabis and Related Pathologies
Editor/Author
Preedy, Victor
Publication Year: 2017
Publisher: Elsevier Science & Technology
Single-User Purchase Price:
$250.00

Unlimited-User Purchase Price:
$375.00
ISBN: 978-0-12-800827-0
Category: Science - Botany
Image Count:
415
Book Status: Available
Table of Contents
Handbook of Cannabis and Related Pathologies: Biology, Pharmacology, Diagnosis, and Treatment is the first book to take an interdisciplinary approach to the understanding of cannabis use and misuse.
This book is found in the following Credo Collections:
Table of Contents
- List of Contributors
- Preface
- I Setting the Scene, Botanical, General and International Aspects
- The Cannabis Plant: Botanical Aspects
- The Biosynthesis of Cannabinoids
- Increasing Plant Concentrations of THC and Implications on Health Related Disorders
- Age as a Predictor of Cannabis Use
- Lifetime Cannabis Use and Cognition in Psychosis Spectrum Disorders
- A Profile of Synthetic Cannabinoid Users
- Dual Disorders in Cannabis Misuse
- Cannabis Use and Cognitive Function
- Cannabis, Migration, and Psychosis Onset
- The Global Epidemiology and Disease Burden of Cannabis Use and Dependence
- International Aspects of Cannabis Use and Misuse: the Australian Perspective
- International Aspects of Cannabis Use and Misuse: Egypt
- Cannabis Body Packing: A Caribbean Perspective
- Tetrahydrocannabinol Concentration and Genetic Characterization of Cannabis
- II Personal, Social and Community Aspects of Cannabis use
- Gender Differences in Cannabis Use Disorders
- The Role of Age in the Onset and Further Development of Cannabis Use Disorders
- Effects of Cannabis Use on Neurocognition in Adolescents and Emerging Adults
- Correlates and Consequences of Prenatal Cannabis Exposure (PCE): Identifying and Characterizing Vulnerable Maternal Populations and Determining Outcomes for Exposed Offspring
- Cannabis and Clubbing: Relevance of Cannabis and Polydrug Use in the Clubbing Culture Today
- Cannabis and Sexual Behavior
- Friendships and Cannabis Use
- Students’ Knowledge of Cannabis
- Childhood Trauma and Cannabis: Risk Factors in Severe Mental Disorders?
- Parent's Influence on Children's Cannabis Use
- Cannabis Users and Premorbid Intellectual Quotient
- Cannabis and Traffic Accidents
- Cannabis Use in Youth Subcultures
- III Cannabis, Behavior, Psychopathology and Neuropathology
- Drug-Related Pictures, Attentional Bias, and Cannabis Use
- Cannabis Use and First-Episode Psychosis Patients (FEP)
- Cannabis, Associative Memory, fMRI, and the Implicit Association Test
- Stress Response in Cannabis Users and Psychosis
- Motivation in Chronic Cannabis Use
- Cannabis Use and Its Association to Mental Illness: A Focus on Mood and Anxiety Disorders
- Cannabis Use and Well-Being
- Craving and Cannabis: A Potential Paradox
- Delta-9-Tetrahydrocannabinol and Catalepsy-Like Immobilization
- The Interactive Nature of Cannabis and Schizophrenia Risk Genes
- Neuroimaging Findings in Adolescent Cannabis Use and Early Phase Psychosis
- Cannabis Smoking in Adult Schizophrenia: A Cognitive and Functional Magnetic Resonance Imaging Perspective
- The Long-Lasting Effects of Cannabis Use on Movement and Brain Regions that Control Movement
- Assessment of Cannabis Acute Effects on Driving Skills: Laboratory, Simulator, and On-Road Studies
- Chronic Cannabis Use and Axonal Fiber Connectivity
- Microglial Activation and Cannabis Exposure
- Cannabis and Psychosis: Correlation, Causality, and Consequences
- Cannabis Use in Bipolar Disorder
- Cannabis Use in Epilepsy—Risks and Benefits
- Cannabis, Cannabinoids, and Visceral Pain
- Cannabis and Postoperative Analgesia
- Aggressive Behavior and Cannabis Use
- COMT Genotypes, Cannabis Use, and Psychosis: Gene-Environment Interaction Evidence from Human Populations, and Its Methodological Concerns
- Neuroimaging and Genetics of the Acute and Chronic Effects of Cannabis
- Gray Matter, Lateral Ventricle Volumes, and Executive Functioning in Cannabis Users with First-Episode Psychosis
- Cannabis Use and Attention-Deficit/Hyperactivity Disorder: Potential Moderators
- IV Cannabis, Organs, Tissues and Non-cns Aspects
- Chronic Cannabis Abuse and Thyroid Function
- Cannabis Hyperemesis Syndrome
- Cannabis and Cannabinoids and the Effects on Gastrointestinal Function: An Overview
- Cardiovascular Effects of Cannabis Usage
- Cannabis and Stroke
- Cannabis Smoking and the Lung
- Cannabis and Hepatic Injury
- Cannabis Allergy: More Than a Bad Trip
- Marijuana and Breastfeeding
- Hypocretins/Orexins and Addiction: Role in Cannabis Dependence
- Regulatory Role of Cannabinoids for Skin Barrier Functions and Cutaneous Inflammation
- Cannabis and Oral Health: Deleterious Effects on Periodontitis and Dental Implants
- Does Cannabis Use Increase the Risk of Developing Cancer in Humans?
- Cannabis and the Use of Amphetamine-Like Substances
- V Pharmacology and Cellular Activities of Cannabinoids and Endocannabinoids
- Cannabinoids and the Cannabinoid Receptors: An Overview
- Signaling and Regulation of the Cannabinoid CB1 Receptor
- Allosteric Modulation of the Cannabinoid CB1 Receptor
- Polymorphisms of the CB2 Cannabinoid Receptor
- Chemistry of Cannabinoid Receptor Agonists
- The Endocannabinoid System as a Target for New Antiseizure Drugs
- Pharmacological Aspects of Anandamide and 2-Arachidonoyglycerol as Bioactive Lipids
- Pharmacological Aspects of NMDA Receptors, mGluR5, and Endocannabinoids
- Peripheral CB1 Receptors and Ghrelin in Feeding Regulation: Pharmacological Implications
- Pharmacological Aspects of Novel Antiobesity Agents Related to Cannabinoids
- Cannabinoid Reward and Dependence: Focus on the Main Psychoactive Ingredients of Marijuana in Preclinical Studies
- Peroxisome Proliferator Activated Receptors and Cannabinoids
- The Protein–Protein Interactions of Cannabinoid Receptor Interacting Protein 1a (CRIP1a) and Cannabinoid 1 Receptor: The Molecular Mechanism Study Through an Integrated Molecular Modeling Approach
- Synthetic Cannabinoids: a Summary of Selected Phenomena With Respect to Behavioral Pharmacology and Abuse Liability
- Cannabinoid Signaling in Glioma Cells and Therapeutic implications
- VI Effects of Specific Natural and Synthetic Cannabinoids
- The Role of 5-HT1A Receptor, and Nausea and Vomiting Relief by Cannabidiol (CBD), Cannabidiolic Acid (CBDA), and Cannabigerol (CBG)
- Genetic and Molecular Aspects of Addiction with Tetrahydrocannabinol
- Effects of Δ9-Tetrahydrocannabinol in Human Breast Cancer
- Δ9-THC and COX-2 Signaling
- Cannabinoids and the Addictive Effects of Nicotine
- Cannabinoid Regulation of Intraocular Pressure: Human and Animal Studies, Cellular and Molecular Targets
- Ocular Delivery of Tetrahydrocannabinol
- The Role of γ-Aminobutyric Acid in the Interoceptive Effects of Oral Δ9-Tetrahydrocannabinol in Humans
- The Role of Δ9-Tetrahydrocannabinol in Diabetes Mellitus
- Cannabidiol: An Overview of its Antipsychotic Properties
- Cannabidiol for the Treatment of Epilepsy: An Overview of Possible Mechanisms of Action and Preclinical and Human Studies
- Cannabidiol and Neuroprotection: Evidence from Preclinical Studies
- Cannabinoids as Potent Inhibitors of Human CYP1 Enzymes
- The Synthetic Analog of Δ9-Tetrahydrocannabinol (THC): Nabilone. Pharmacology and Clinical Application
- Synthetic Cannabinoids in Dementia
- Synthetic Cannabinoid Receptor Agonists (Spice) as New Recreational Psychoactive Substances
- Accidents and Synthetic Cannabinoids in Blood of Drivers
- Cannabidiol as an Antioxidant
- The Anxiolytic Effects of Cannabidiol (CBD)
- New Ethological and Morphological Perspectives for the Investigation of Panicolytic-Like Effects of Cannabidiol
- Spice Use Among United States Military Personnel
- VII Medicinal Cannabis use
- Cannabis and Synthetic Cannabinoids for Cancer Patients: Multiple Palliative Indications Together With Promising Laboratory Antineoplastic Effects
- The Use of Medical Marijuana in the Treatment of Psychiatric Disorders
- Beneficial Effects of Cannabis and Related Compounds on Sleep
- Cannabinoid-Based Medicines for the Treatment of Gilles de la Tourette Syndrome
- Cannabidiol and Multiple Sclerosis
- Cannabinoids and Their Effects on Painful Neuropathy
- Cannabis for Basal Ganglia Disorders (Parkinson Disease and Huntington Disease)
- Medical Cannabis for the Treatment of Inflammatory Bowel Disease
- Cannabidiol for the Treatment of Drug Use Disorders
- Cannabinoids and Effects on the Gastrointestinal Tract: A Focus on Motility
- Potential Medical Uses of Cannabigerol: A Brief Overview
- Cannabis Use in Fibromyalgia
- VIII Screening, Diagnosis, and Treatment
- The Cannabis Abuse Screening Test (CAST) and Its Applications
- Screening of Synthetic Cannabinoids
- On-Site Drug Testing for Cannabis
- Cannabinoids in Oral Fluid: Identification and Interpretation of Analytical Results
- Cannabinoids in Exhaled Breath
- Barriers to Treatment Seeking for Cannabis Dependence
- Pharmacotherapies for Cannabis Use Disorders
- Self-Initiated Cannabis Use Cessation in Adolescents and Emerging Adults
- Treating Cannabis-Dependent Adolescents with Family Therapy: The case of Multidimensional Family Therapy
- Cognitive Behavioral Therapy in Cannabis Use Disorder
- The Cannabis Withdrawal Syndrome— Symptoms and Time Course
- School-Based Cannabis Prevention Programs
- The CapOpus Trial for Cannabis Use Disorders
- Treating Cannabis Use Disorders Through Technology-Assisted Interventions: the Telephone and Internet
- Reducing Cannabis Use With a Real-Time Intervention Using Mobile Technology
- Short Instruments to Screen for “Problematic” Cannabis Use in General Population Surveys
- Self-report of Cannabis Use
- CANDIS Program: Modular Treatment of Cannabis Use Disorders
- Engaging Cannabis Users in Treatment
- Cannabis Neuropathology Resources and Recommended Reading